RxLedger

Aurobindo Pharm — Medicare Part D spending

Rank #20 by attributed Part D spend · 62 tracked drugs · CMS data year 2023

About $2,896,013,808 of Medicare Part D spending in 2023 is attributed to Aurobindo Pharm across the 62 of its drugs tracked here, ranking it #20 among manufacturers on this site. Its biggest Part D drug is Pantoprazole Sodium* at $384,047,698. Attribution uses the CMS manufacturer lists and is indicative, not definitive. These are aggregate program figures, not the price you pay.

Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.

Aurobindo Pharm drugs in Medicare Part D (2023)

BrandGenericTotal spendPer dosage unitBeneficiariesSpend rank
<a href="/drug/pantoprazole-sodium-pantoprazole-sodium/">Pantoprazole Sodium*</a>Pantoprazole Sodium$384,047,698$0.256,191,845#145
<a href="/drug/imatinib-mesylate-imatinib-mesylate/">Imatinib Mesylate</a>Imatinib Mesylate$211,095,557$49.9914,613#211
<a href="/drug/clopidogrel-clopidogrel-bisulfate/">Clopidogrel</a>Clopidogrel Bisulfate$201,696,339$0.243,259,636#216
<a href="/drug/sevelamer-carbonate-sevelamer-carbonate/">Sevelamer Carbonate</a>Sevelamer Carbonate$189,369,170$1.20185,489#235
<a href="/drug/mirtazapine-mirtazapine/">Mirtazapine</a>Mirtazapine$176,432,051$0.561,551,607#255
<a href="/drug/sertraline-hcl-sertraline-hcl/">Sertraline HCl</a>Sertraline HCl$173,568,167$0.193,041,276#261
<a href="/drug/venlafaxine-hcl-er-venlafaxine-hcl/">Venlafaxine HCl ER</a>Venlafaxine HCl$151,208,248$0.46954,551#292
<a href="/drug/losartan-hydrochlorothiazide-losartan-hydrochlorothiazide/">Losartan-Hydrochlorothiazide</a>Losartan/Hydrochlorothiazide$118,183,005$0.291,380,777#347
FinasterideFinasteride$111,453,116$0.231,723,562#367
Fluoxetine HClFluoxetine HCl$104,951,776$0.221,427,221#378
ClozapineClozapine$85,570,390$1.3364,860#443
Amiodarone HCl*Amiodarone HCl$84,840,881$0.52797,134#446
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav$78,161,560$0.625,205,096#464
LamotrigineLamotrigine$70,895,417$0.21611,083#501
Methenamine HippurateMethenamine Hippurate$62,069,964$1.13161,162#549
Ondansetron HCl*Ondansetron HCl$57,500,958$0.432,094,495#573
Raloxifene HClRaloxifene HCl$54,735,238$1.13169,339#586
Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril$42,438,721$0.33419,160#660
CefdinirCefdinir$41,866,471$1.261,621,815#665
ModafinilModafinil$41,700,366$2.4269,010#668
Ciprofloxacin HCl*Ciprofloxacin HCl$39,024,544$0.663,519,833#691
Benazepril HClBenazepril HCl$37,037,536$0.20540,761#711
Prasugrel HClPrasugrel HCl$30,426,210$1.5085,432#785
Sulfamethoxazole-Trimethoprim*Sulfamethoxazole/Trimethoprim$28,506,828$0.323,086,523#813
Risedronate SodiumRisedronate Sodium$27,199,300$32.6371,989#832
Efavirenz-Emtric-Tenofov DisopEfavirenz/Emtricit/Tenofovr Df$25,471,620$28.243,189#864
RamiprilRamipril$24,384,523$0.16388,707#887
Cefpodoxime ProxetilCefpodoxime Proxetil$24,258,363$3.83330,545#889
Dorzolamide-TimololDorzolamide/Timolol/PF$21,574,654$1.8734,338#931
Clindamycin HClClindamycin HCl$21,121,257$0.381,633,351#937
RizatriptanRizatriptan Benzoate$18,724,756$2.17180,679#984
Clorazepate DipotassiumClorazepate Dipotassium$16,602,385$1.8626,466#1023
Rabeprazole SodiumRabeprazole Sodium$15,263,158$0.7965,972#1056
Propafenone HClPropafenone HCl$14,451,904$0.4551,674#1087
Galantamine ERGalantamine HBr$13,463,699$2.2324,725#1114
Tamoxifen CitrateTamoxifen Citrate$12,643,105$0.4997,487#1147
ArmodafinilArmodafinil$11,834,290$2.5521,855#1168
Terbinafine HClTerbinafine HCl$11,567,666$0.38415,181#1174
RitonavirRitonavir$9,760,185$3.317,866#1243
CarbidopaCarbidopa$8,630,589$2.684,842#1292

Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.

Frequently asked questions

How much Medicare Part D spending does Aurobindo Pharm get?

In 2023, about $2,896,013,808 of Medicare Part D spending is attributed to Aurobindo Pharm across the 62 of its drugs tracked here. Its biggest is Pantoprazole Sodium* at $384,047,698. This is gross program spending, not what patients pay. Source: CMS, data year 2023.

What is Aurobindo Pharm's top Medicare Part D drug?

Among the drugs tracked here, Aurobindo Pharm's highest Part D spending in 2023 is Pantoprazole Sodium* at $384,047,698 (national rank #145 by total spend).

Is manufacturer attribution exact?

No. CMS may list multiple manufacturers per drug, and labeler relationships change over time. We attribute each drug to its primary listed manufacturer, so these rollups are indicative rather than definitive. Always check the underlying CMS file for a specific drug.

Keep exploring

Data: CMS Medicare Part D Spending by Drug (data year 2023), U.S. public domain. Aggregate program spending, not prices. Data as of June 2026. See our methodology and disclaimer.

Last updated: 2026-06-21